Ações de um Agonista de Receptores Imidazolínicos...
REFERÊNCIAS
91
Sims HP, Tarazi R. Report of the Hypertension Task Force, Volume 9. Washington, DC: US
Government Printing Office 1979;61-77. US Dept of Health, Education, and Welfare
publication 70-1631 (NIH).
Smyth DD, Penner SB. Peripheral and central imidazolinic receptor-mediated natriuris in the
rat. Ann N Y Acad Sci 1999;881:144-157.
Stamler RA, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure
findings in hypertension secreening of 1 million Americans. JAMA 1978;240:1607-1610.
Stepniakowski KT, Goodfriend TL, Egan BM. Fatty acids enhance vascular a-adrenergic
sensitivity. Hypertension 1995;25:774-778.
Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature
2001;409:307-12.
Sugenoya J, Iwasc S, Mano T, Sugiyama Y, Ogawa Y, Nishiyama T, et al . Vasodilataor
component in sympathetic nerve activity destined for the skin of the dorsal foot of mildiy
heated humans. J Phisiol ( Lond) 1998;507:603-610.
Suhayla Mukaddam-Daher, Jolanta Gutkowska. Atrial natriuretic peptide is involved in renal
actions of moxonidine. Hypertension 2000;35:1215-1220.
Suter PM, Locher R, Häsler E, Vetter W. Is there a role for the ob gene product leptin in
essential hypertension? Am J Hypertens 1998;11:1305-1311.
Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield
LA, Clark FT, Deeds J, et al. Identification and expression cloning of a leptin receptor, Ob-R.
Cells 1997; 83: 1263-1271.
The Third Report of the National Cholesterol Education Program Expert Panel on Detection,
Evaluation, and Treatment of Higth Blood Cholesterol in Adults (Adult Treatment Panel III,
2001). JAMA 2001;285:2486-2497.
Thornton JE, Chueng CC, Clifton DK, Steiner RA: Regulation of hypothalamic
proopiomelanocortin mRNA by leptin in ob/ob mice. Nature 1994;372:425-432.
Tibiriçá E, Feldman J, Mermet C, Monassier L, Gonon F, Bousquet P. Selectivity of
rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing
imidazoline preferring receptors. Eur J Pharmacol 1991;209:213-225.
Trieb G, Jager B, Hughers PR, et al. Long-term evaluation of the antihypertensive efficacy
and tolerability of the orally-acting imidazoline I 1 receptor agonist moxonidine in patients
with mild to moderate essential hypertension. Eur J Clin Res 1995;7:227-240.
Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and
diet to sympathetic nervous system activity. Hypertension 1991;17:669-677.
Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on
blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N
Engl J Med 1981;304:930-933.
Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension.
Hypertension 1992;19(suppl I):I-67-I-77.